Home Compare DVA vs HCA
Stock Comparison · Industry comparison · Medical Care Facilities

DaVita vs HCA Healthcare: Which Stock Looks Stronger in 2026?

HCA Healthcare holds the cleaner structural position, with profitability as the main driver and growth adding further support. The remaining gap is narrow enough that the comparison remains open to different readings. On the market side, HCA Healthcare is in better shape — its trend is intact while DaVita's trend has broken down. That puts structure and market broadly in agreement — HCA Healthcare's lead looks more confirmed than conflicted.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The comparison is mainly decided in profitability, with the rest of the profile carrying less weight.

INDUSTRY COMPARISON

Both operate in: Medical Care Facilities

This comparison is based on industry proximity, not on functional trajectory similarity. DVA and HCA share the same industry classification.

For a similarity-based comparison, see how DaVita and HCA Healthcare each position within their functional peer groups in AssetNext.

Peer-Relative Score
DVA
DaVita Inc.
64
Peer-Score
Signal qualityMedium
vs
HCA
HCA Healthcare, Inc.
70
Peer-Score
Signal qualityMedium

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in profitability.

Dimension spread: DVA vs HCA Profitability 51 72 Stability 58 58 Valuation 82 84 Growth 64 59 DVA HCA
Gap Ranking
#1 Profitability +21
#2 Growth +5
#3 Valuation +2
#4 Stability
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for DVA and HCA Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer DVAHCA Relative valuation Structural strength

The setup is mixed: neither company clearly combines the stronger profile with the more supportive price setup.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Profitability
Both look solid on profitability, though HCA Healthcare, Inc. still holds the stronger peer position.
Profitability — Dominant Gap
DVA
51
HCA
72
Gap+21in favour of HCA

Capital efficiency adds support, with a 9.9-point ROIC advantage.

What keeps the gap from being one-sided

DaVita Inc. still shows lower market-fundamental divergence, which keeps the wider picture mixed rather than completely one-sided.

What this means for the comparison

Profitability is the clearest driver, and growth also supports HCA Healthcare, Inc.'s broader structural position.

Explore full peer positioning in AssetNext

Break down the DVA vs HCA comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar profitability-and-growth comparisons

Explore how DVA and HCA each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.